Rigetti Computing Insider Sold Shares Worth $2,782,889, According to a Recent SEC Filing-January 2024-www.financetom.com

Rigetti Computing Insider Sold Shares Worth $2,782,889, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Rigetti Computing Insider Sold Shares Worth $2,782,889, According to a Recent SEC Filing

Oct 17, 2025 2:02 PM

04:38 PM EDT, 10/17/2025 (MT Newswires) -- Helene Gail Sandford, Director, on October 17, 2025, sold 62,000 shares in Rigetti Computing ( RGTI ) for $2,782,889. Following the Form 4 filing with the SEC, Sandford has control over a total of 120,371 shares of the company, with 120,371 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1838359/000112329225000568/xslF345X05/form4.xml

Previous page： --Netflix Posts Q2 EPS of $4.88 on Revenue of $9.6 Billion, vs CIQ Analyst Consensus of $4.76/Share on Revenue of $9.5 Billion Next page： --Netflix Reports Q2 Earnings of $4.88 a Share vs. Street Estimate of $4.74

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Netflix Posts Q2 EPS of $4.88 on Revenue of $9.6 Billion, vs CIQ Analyst Consensus of $4.76/Share on Revenue of $9.5 Billion

Jul 18, 2024

04:00 PM EDT, 07/18/2024 (MT Newswires) -- Price: 642.95, Change: -4.51, Percent Change: -0.70 ...

--Netflix Reports Q2 Earnings of $4.88 a Share vs. Street Estimate of $4.74

Jul 18, 2024

04:02 PM EDT, 07/18/2024 (MT Newswires) -- Price: 619.94, Change: -23.10, Percent Change: -3.59 ...

Dr. Reddy's Laboratories to Market Takeda's Acid-Reflux Medication in India

Jul 18, 2024

04:01 PM EDT, 07/18/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) on Thursday disclosed plans to commercialize and sell Takeda Pharmaceutical's ( TAK ) vonoprazan tablets to treat gastroesophageal reflux disease, peptic and duodenal ulcers and similar disorders to customers in India. Under the terms of the non-exclusive patent licensing agreement, Dr. Reddy's plans to market the orally active potassium...

Benson Hill Plans 1-for-35 Reverse Stock Split to Regain NYSE Compliance

Jul 18, 2024

04:02 PM EDT, 07/18/2024 (MT Newswires) -- Benson Hill ( BHIL ) is planning a 1-for-35 reverse split of its common stock to take effect after Thursday's market close after the proposal was approved earlier in the day by shareholders at its annual meeting. The crop genetics company said the reverse split is intended to help it regain compliance with...